E-LIB Suche - Ergebnisse für: Muñoz Couselo, Eva

1

SEOM-GEM clinical guidelines for cutaneous melanoma (2023):

Márquez-Rodas, Iván ; Muñoz Couselo, Eva ; Rodríguez Moreno, Juan F....
Clinical and Translational Oncology. , 2024

Link: https://doi.org/10.1007/..

2

Phase 1, first-in-human study of TYRP1-TCB (RO7293583), a n..:

Spreafico, Anna ; Couselo, Eva Muñoz ; Irmisch, Anja...
Frontiers in Oncology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

3

Combined immunotherapy in melanoma patients with brain meta..:

Mandalà, Mario ; Lorigan, Paul ; Sergi, Maria Chiara...
European Journal of Cancer. 199 (2024) - p. 113542 , 2024

Link: https://doi.org/10.1016/..

4

A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab..:

Weiss, Sarah A. ; Sznol, Mario ; Shaheen, Montaser...
Clinical Cancer Research. 30 (2023) 1 - p. 74-81 , 2023

Link: https://doi.org/10.1158/..

5

Mucosal Melanoma Clinical Management and Prognostic Implica..:

Clavero-Rovira, Laia ; Gómez-Tomás, Álvaro ; Bassas-Freixas, Patricia...
Cancers. 16 (2024) 1 - p. 227 , 2024

Link: https://doi.org/10.3390/..

6

Access to melanoma drugs in Spain: a cross-sectional survey:

Gonzalez-Cao, Maria ; Puertolas, Teresa ; Manzano, Jose Luis...
Clinical and Translational Oncology. , 2024

Link: https://doi.org/10.1007/..

7

Complete response of metastatic cutaneous squamous cell car..:

González-Cruz, Carlos ; Muñoz-Couselo, Eva ; Ortiz-Velez, Carolina...
JAAD Case Reports. 46 (2024) - p. 67-69 , 2024

Link: https://doi.org/10.1016/..

8

Access to systemic treatment of non-melanoma skin cancer in..:

Cerezuela-Fuentes, Pablo ; Gonzalez-Cao, Maria ; Puertolas, Teresa...
Clinical and Translational Oncology. , 2024

Link: https://doi.org/10.1007/..

9

A two-step algorithm avoids corticosteroids in two-thirds o..:

Barciela, Mar Riveiro ; Barreira, Ana ; Salcedo, María-Teresa...
Journal of Hepatology. 78 (2023) - p. S375-S376 , 2023

Link: https://doi.org/10.1016/..

10

Efficacy and safety of cosibelimab, an anti-PD-L1 antibody,..:

Clingan, Philip ; Ladwa, Rahul ; Brungs, Daniel...
Journal for ImmunoTherapy of Cancer. 11 (2023) 10 - p. e007637 , 2023

Link: https://doi.org/10.1136/..

11

Exploring the Immunogenicity of Noncanonical HLA-I Tumor Li..:

Lozano-Rabella, Maria ; Garcia-Garijo, Andrea ; Palomero, Jara...
Clinical Cancer Research. 29 (2023) 12 - p. 2250-2265 , 2023

Link: https://doi.org/10.1158/..

12

A pan-cancer clinical platform to predict immunotherapy out..:

Hernando-Calvo, Alberto ; Vila-Casadesús, Maria ; Bareche, Yacine...
Med. 4 (2023) 10 - p. 710-727.e5 , 2023

Link: https://doi.org/10.1016/..

13

Phase 2 confirmatory study of cemiplimab (350 mg IV Q3W) in..:

Hughes, Brett ; Grob, Jean-Jacques ; Bowyer, Samantha...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 2 - p. s175 , 2023

Link: https://doi.org/10.25251..

14

Impact of pembrolizumab versus chemotherapy on health-relat..:

Schmid, Peter ; Lipatov, Oleg ; Im, Seock-Ah...
European Journal of Cancer. 195 (2023) - p. 113393 , 2023

Link: https://doi.org/10.1016/..

15

Efficacy and safety of immune checkpoint inhibitors in youn..:

Wong, Selina K. ; Blum, Steven M. ; Sun, Xiaopeng...
European Journal of Cancer. 181 (2023) - p. 188-197 , 2023

Link: https://doi.org/10.1016/..